Efficacy of Trans-spinal Magnetic Stimulation on Functional Mobility in Chronic Stroke Patients
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 30
- 试验地点
- 6
- 主要终点
- Functional Mobility
研究概览
简要总结
The goal of this clinical trial is to learn if trans-spinal magnetic stimulation works to treat gait disorders in chronic stroke adults. It will also learn about the safety of trans-spinal magnetic stimulation.
The main questions it aims to answer are:
Does trans-spinal magnetic stimulation enhance chronic stroke participants gait and functional mobility? Does the technique cause any side effects?
Researchers will compare trans-spinal magnetic stimulation to a sham (a look-alike stimulation with no real effect) to see if trans-spinal magnetic stimulation works to treat gait disorders and improve functional mobility.
Participants will:
Receive trans-spinal magnetic stimulation with treadmill training or a sham stimulation with treadmill training every day for 2 weeks.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Triple (Participant, Care Provider, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 75 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Confirmation of Stroke by digital or physical imaging or medical report
- •Gait impairment
- •Stroke with at least 6 months after ictus
排除标准
- •Metallic implants in spinal cord
- •Major orthopedic/rheumatological disorders
- •Incapacity of verbal or non-verbal communication
结局指标
主要结局
Functional Mobility
时间窗: Enrollment (Day 0); End of treatment (2 weeks); Follow-up after 30 days post-treatment
The Timed-Up and Go (TUG) test is used to evaluate an individual´s capacity to stand up, walk, and sit down. During the test, the participants are timed from the moment they begin to stand up until they are seated again.
次要结局
- Independency level(Enrollment (Day 0); End of treatment (2 weeks); Follow-up after 30 days post-treatment)
- Balance(Enrollment (Day 0); End of treatment (2 weeks); Follow-up after 30 days post-treatment)
- Sensory Function(Enrollment (Day 0); End of treatment (2 weeks); Follow-up after 30 days post-treatment)
- Spasticity(Enrollment (Day 0); End of treatment (2 weeks); Follow-up after 30 days post-treatment)
- Lower limb motor function(Enrollment (Day 0); End of treatment (2 weeks); Follow-up after 30 days post-treatment)
- Perceived change in treatment(End of treatment (2 weeks))
研究者
Kátia Monte-Silva
Professor
Universidade Federal de Pernambuco